Free Trial
ASX:EMR

Emerald Resources (EMR) Stock Price, News & Analysis

Emerald Resources logo

About Emerald Resources Stock (ASX:EMR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
133,510 shs
Average Volume
N/A
Market Capitalization
$2.74 billion
P/E Ratio
30.11
Dividend Yield
5.06%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Emerald Resources NL engages in the exploration and development of mineral reserves in Cambodia and Australia. The company's exploration tenements include a combination of 100% owned granted licenses, applications, and earn-in and joint venture agreements covering a combined area of 1,239 square kilometers. Its principal property is the Okvau Gold project located in the city of Phnom Penh, province of Mondulkiri. The company was formerly known as Emerald Oil & Gas NL and changed its name to Emerald Resources NL in December 2014. The company was incorporated in 1969 and is headquartered in West Perth, Australia.

Receive EMR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Emerald Resources and its competitors with MarketBeat's FREE daily newsletter.

EMR Stock News Headlines

Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.
ASX Growth Stocks With High Insider Ownership
See More Headlines

EMR Stock Analysis - Frequently Asked Questions

Emerald Resources NL (ASX:EMR) announced its quarterly earnings data on Friday, March, 16th. The company reported $0.00 earnings per share (EPS) for the quarter. Emerald Resources had a trailing twelve-month return on equity of 17.12% and a net margin of 22.83%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Emerald Resources investors own include Johnson & Johnson (JNJ), Medtronic (MDT), PepsiCo (PEP), Chevron (CVX), Abbott Laboratories (ABT), Lowe's Companies (LOW) and Merck & Co., Inc. (MRK).

Company Calendar

Last Earnings
3/16/2018
Today
5/17/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Gold
Sub-Industry
N/A
Current Symbol
ASX:EMR
CIK
N/A
Fax
N/A
Employees
280
Year Founded
N/A

Profitability

Trailing P/E Ratio
30.11
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$84.27 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$372.96 million
Price / Cash Flow
14.00
Book Value
A$0.92 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$2.74 billion
Optionable
Not Optionable
Beta
1.06
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (ASX:EMR) was last updated on 5/17/2025 by MarketBeat.com Staff
From Our Partners